Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Rating) and Aziyo Biologics (NASDAQ:AZYO – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, valuation, dividends and profitability. Volatility & Risk Eloxx Pharmaceuticals has a beta of […]
Eloxx Pharmaceuticals (ELOX) Granted FDA Clearance to Begin Single Ascending Dose Study of ZKN-013 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Rating) saw a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 206,200 shares, an increase of 320.8% from the March 31st total of 49,000 shares. Based on an average daily trading volume, of 238,700 shares, the days-to-cover ratio […]
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Rating) was the recipient of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 206,200 shares, an increase of 320.8% from the March 31st total of 49,000 shares. Based on an average daily volume of 238,700 shares, the […]
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Rating) saw a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 206,200 shares, a growth of 320.8% from the March 31st total of 49,000 shares. Currently, 14.1% of the company’s shares are short sold. Based on an average […]